Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Fish and Richardson
Argus Health

Generated: December 16, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

When do Ciclopirox patents expire, and when can generic versions of Ciclopirox launch?

Ciclopirox is a drug marketed by Fougera Pharms, G And W Labs Inc, Glenmark Pharms, Perrigo New York, Taro, Cnty Line Pharms, Glenmark Generics, Paddock Llc, Actavis Mid Atlantic, Perrigo Co, Akorn, Apotex Inc, Cipla Ltd, G And W Labs, Hi Tech Pharma, Mylan Pharms Inc, Taro Pharm Inds, Teva Pharms, and Tolmar. and is included in twenty-seven NDAs. There are two patents protecting this drug.

This drug has forty-three patent family members in thirty-four countries.

The generic ingredient in CICLOPIROX is ciclopirox. There are ten drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ciclopirox profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
TaroCICLOPIROXciclopiroxSUSPENSION;TOPICAL077092-001Aug 10, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Fougera PharmsCICLOPIROXciclopiroxCREAM;TOPICAL076435-001Dec 29, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla LtdCICLOPIROXciclopiroxSOLUTION;TOPICAL078124-001Sep 18, 2007ATRXNoNo► Subscribe► Subscribe► Subscribe
Teva PharmsCICLOPIROXciclopiroxSOLUTION;TOPICAL078079-001Sep 18, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Cnty Line PharmsCICLOPIROXciclopiroxGEL;TOPICAL020519-001Jul 21, 1997ABRXYesYes► Subscribe► Subscribe► Subscribe
Perrigo New YorkCICLOPIROXciclopiroxCREAM;TOPICAL077364-001Mar 3, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Fougera PharmsCICLOPIROXciclopiroxSHAMPOO;TOPICAL090146-001May 25, 2010ATRXNoNo► Subscribe► Subscribe► Subscribe
Hi Tech PharmaCICLOPIROXciclopiroxSOLUTION;TOPICAL078270-001Sep 18, 2007ATRXNoNo► Subscribe► Subscribe► Subscribe
Fougera PharmsCICLOPIROXciclopiroxGEL;TOPICAL077896-001Jun 10, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
G And W LabsCICLOPIROXciclopiroxSOLUTION;TOPICAL078233-001Sep 18, 2007ATRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Premature patent expiration for: CICLOPIROX

Expiration due to failure to pay maintenance fee

Patent Number Tradename Expiration Date
► Subscribe CICLOPIROX ► Subscribe

International Patent Family for Tradename: CICLOPIROX

Country Document Number Estimated Expiration
Poland188840► Subscribe
Poland332604► Subscribe
Portugal928192► Subscribe
Yugoslavia13599► Subscribe
Canada2267160► Subscribe
African Intellectual Property Organization (OAPI)11026► Subscribe
Serbia49596► Subscribe
Spain2176702► Subscribe
Turkey9900723► Subscribe
Germany19639816► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: